Pages that link to "Q44247511"
Jump to navigation
Jump to search
The following pages link to Meta-analysis of results from eight randomized, placebo-controlled trials on the effect of cilostazol on patients with intermittent claudication (Q44247511):
Displaying 50 items.
- Cilostazol for intermittent claudication (Q24193019) (← links)
- Cilostazol for peripheral arterial disease (Q24242765) (← links)
- Cilostazol for peripheral arterial disease (Q24246227) (← links)
- Peripheral Arterial Disease in Patients with Type 2 Diabetes Mellitus (Q26795374) (← links)
- Comparative Efficacy and Safety of Different Antiplatelet Agents for Prevention of Major Cardiovascular Events and Leg Amputations in Patients with Peripheral Arterial Disease: A Systematic Review and Network Meta-Analysis (Q26798134) (← links)
- Anti‐platelet therapy: phosphodiesterase inhibitors (Q27687228) (← links)
- Drug treatment of peripheral arterial disease in the elderly (Q28195312) (← links)
- Practice-based evidence: profiling the safety of cilostazol by text-mining of clinical notes (Q28533275) (← links)
- Design of the START-trial: STimulation of ARTeriogenesis using subcutaneous application of GM-CSF as a new treatment for peripheral vascular disease. A randomized, double-blind, placebo-controlled trial (Q33198730) (← links)
- Current approach to the diagnosis and treatment of femoral-popliteal arterial disease. A systematic review (Q33743880) (← links)
- Open-Label Phase I Clinical Study to Assess the Safety and Efficacy of Cilostazol in Patients Undergoing Internal Carotid Artery Stent Placement (Q33781981) (← links)
- A pooled analysis of the durability and predictors of treatment response of cilostazol in patients with intermittent claudication (Q33903841) (← links)
- Peripheral artery disease: current insight into the disease and its diagnosis and management (Q33951581) (← links)
- Cilostazol Stimulates Revascularisation in Response to Ischaemia via an eNOS-Dependent Mechanism (Q33996451) (← links)
- Office evaluation of leg pain (Q34563715) (← links)
- Profile of atherosclerotic risk factors and management in patients of peripheral arterial disease at a tertiary care teaching hospital of north India (Q34949365) (← links)
- Platelets, atherosclerosis and the endothelium: new therapeutic targets? (Q35570940) (← links)
- Antiplatelet drugs: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (Q35752619) (← links)
- Optimal management of peripheral arterial disease for the non-specialist (Q35761784) (← links)
- Can endovascular therapy of infrainguinal disease for claudication be justified? (Q35777360) (← links)
- Cilostazol: improving walking distance in patients with intermittent claudication (Q35821880) (← links)
- Peripheral arterial disease of the lower extremities (Q35990502) (← links)
- Leg ulcers and pain: a review (Q36113676) (← links)
- Comparison of the results of percutaneous transluminal angioplasty and stenting with medical treatment for claudicants who have superficial femoral artery occlusive disease (Q36587019) (← links)
- Optimal medical management of peripheral arterial disease (Q36588669) (← links)
- Management of peripheral arterial disease in the elderly: focus on cilostazol (Q36892864) (← links)
- Targeting phosphodiesterases in anti-platelet therapy (Q36929627) (← links)
- Antiplatelet Effect of Sequential Administration of Cilostazol in Patients with Acetylsalycilic Acid Resistance. (Q36946112) (← links)
- Peripheral arterial disease in the elderly (Q37069056) (← links)
- Platelet activation, and antiplatelet targets and agents: current and novel strategies. (Q37235603) (← links)
- Peripheral arterial disease: Epidemiology, natural history, diagnosis and treatment. (Q37321632) (← links)
- Pharmacologic therapy for intermittent claudication (Q37461418) (← links)
- Treatment strategies for peripheral artery disease (Q37519704) (← links)
- The burden of peripheral artery disease and the role of antiplatelet therapy (Q37566082) (← links)
- Cilostazol and atherogenic dyslipidemia: a clinically relevant effect? (Q37834033) (← links)
- The role of antiplatelets in hypertension and diabetes mellitus (Q37861894) (← links)
- Beyond Aspirin and Clopidogrel: Is There a Need for Additional Antiplatelet Therapy in ACS? (Q37878982) (← links)
- Peripheral artery disease. Part 2: medical and endovascular treatment (Q37889106) (← links)
- Role of Phosphodiesterases in Adult-Onset Pulmonary Arterial Hypertension (Q37893073) (← links)
- Comprehensive Medical Management of Peripheral Arterial Disease (Q37896764) (← links)
- Perspectives on Optimizing Trial Design and Endpoints in Peripheral Arterial Disease: A Case for Imaging-Based Surrogates as Endpoints of Functional Efficacy (Q37908732) (← links)
- Current Therapeutic Strategies to Mitigate the eNOS Dysfunction in Ischaemic Stroke (Q37971308) (← links)
- Supervised exercise therapy for intermittent claudication: current status and future perspectives. (Q37983543) (← links)
- Preventive aspects in peripheral artery disease (Q37984281) (← links)
- Medical management for chronic atherosclerotic peripheral arterial disease (Q38050495) (← links)
- Endothelial shear stress and blood viscosity in peripheral arterial disease (Q38187356) (← links)
- Pharmacological treatment and therapeutic perspectives of metabolic syndrome. (Q38262435) (← links)
- Percutaneous versus surgical management of lower extremity peripheral artery disease (Q38328898) (← links)
- Peripheral interventions and antiplatelet therapy: Role in current practice (Q38616610) (← links)
- Current therapies and investigational drugs for peripheral arterial disease (Q38657444) (← links)